MITA News
-
MITA Statement
The Medical Imaging & Technology Alliance (MITA) today issued the following statement from Executive Director Gail Rodriguez in response to the Congressional Budget Office’s (CBO) Estimated Effects on Direct Spending and Revenues for Health Care Programs of Proposals in the President’s 2014 Budget…
-
MITA Statement
The Medical Imaging & Technology Alliance (MITA) today applauded Doc Hastings (R-WA) and Edward “Ed” Markey (D-MA) for their leadership in the passage of bipartisan legislation to prevent the premature closure of the Federal Helium Reserve. The Responsible Helium Administration and Stewardship Act (H.R. 527) passed by a vote of 394 to 1.
-
MITA Statement
The Medical Imaging & Technology Alliance (MITA) applauded Energy and Natural Resources Committee Chairman, Senator Ron Wyden, D-OR, and Ranking Member, Senator Lisa Murkowski, R-AK, for their bipartisan efforts to safeguard access to helium by yesterday introducing the Helium Stewardship Act of 2013 to prevent the premature closure of the Federal Helium Reserve.
-
MITA Statement
The medical technology industry represented by AdvaMed, COCIR, Eucomed, EDMA and MITA met yesterday with senior U.S. and E.U. government officials as part of the U.S.-E.U. High Level Regulatory Cooperation Forum urging them to consider regulatory convergence for medical technology in upcoming negotiations on the Transatlantic Trade and Investment Partnership (TTIP).
-
MITA Statement
The Medical Imaging & Technology Alliance (MITA) today expressed concern about President Obama’s proposed 2014 budget, which again includes a recommendation for a prior authorization system through for-profit radiology benefit managers (RBMs). This provision was included in spite of the Office of Management and Budget (OMB)’s acknowledgement that a prior authorization policy will yield no savings. If instituted, this proposal will jeopardize both innovation and patient access to imaging technologies that have proven time and again to save lives and lower long-term health care costs.
-
MITA Statement 03.21.13
Medical Device Manufacturing Coalition Applauds Passage of Medical Device Tax Repeal Amendment
The Medical Imaging & Technology Alliance (MITA), Advanced Medical Technology Association (AdvaMed) and the Medical Device Manufacturers Association (MDMA) today applauded the adoption of an amendment to the Fiscal Year 2014 Senate Budget Resolution that expresses support for repeal of the medical device tax. The amendment passed with 79 votes.
-
MITA Statement 03.20.13
MITA Commends Continued Bipartisan House Progress on Protecting Access to Critical Helium Supply
The Medical Imaging & Technology Alliance (MITA) applauded Representatives Doc Hastings (R-WA) and Edward “Ed” Markey (D-MA) for their bipartisan work to keep the Federal Helium Reserve operational by today holding a markup of the Responsible Helium Administration and Stewardship Act (H.R. 527). H.R. 527 prevents the premature closure of the Federal Helium Reserve this year.
-
MITA Statement
The Medical Imaging & Technology Alliance (MITA) today announced the approval of XR-29 Standard Attributes on Computed Tomography (CT) Equipment Related to Dose Optimization and Management. XR-29, also known as MITA Smart Dose, includes four key features of CT equipment that enable optimization or management of radiation dose delivery while also providing high quality medical images.
-
MITA Statement
The Medical Imaging & Technology Alliance (MITA) today applauded Representatives Ralph Hall (R-TX) and Danny Davis (D-IL) for reintroducing the “CT Colonography Screening for Colorectal Cancer Act” (H.R. 991), which would ensure Medicare coverage of computed tomography (CT) colonography, also known as “virtual colonoscopy.” MITA has long supported a national coverage decision for CT colonography to expand access to the technology and save lives.
-
MITA Statement
The Medical Imaging & Technology Alliance (MITA) today issued the following response from Executive Director Gail Rodriguez on the decision made by the Centers for Medicare & Medicaid Services (CMS) to remove the national non-coverage decision for positron emission tomography (PET) for FDA-approved oncologic applications.
Medical Imaging Community Rallies Against Device Tax
MITA and its industry partners, including AdvaMed and MDMA, are calling on Congress to pass bipartisan legislation that repeals the medical device tax in a new ad campaign. Learn More
MITA Urges Congress to Reject Reimbursement Cuts
MITA calls on policymakers to protect access to life saving medical imaging technologies. Learn More
Why I Joined MITA – Navidea Biopharmaceuticals
Hear from Thomas Tulip, Executive Vice President and Chief Business Officer of Navidea Biopharmaceuticals, on why his organization joined MITA.
